Chiron Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$10.4M |
| 2 |
AT&T
T
|
+$3.03M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$1.42M |
| 4 |
K
Kellanova
K
|
+$1.24M |
| 5 |
Skyworks Solutions
SWKS
|
+$1.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.43M |
| 2 |
Pfizer
PFE
|
+$1.38M |
| 3 |
Lockheed Martin
LMT
|
+$1.3M |
| 4 |
SLB Ltd
SLB
|
+$1.19M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.45% |
| 2 | Technology | 9.23% |
| 3 | Communication Services | 8.52% |
| 4 | Consumer Staples | 5.62% |
| 5 | Consumer Discretionary | 4.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CVS Health
CVS
$122B
| – | – |
-6,370
| Closed | -$657K |
|
127
Edison International
EIX
$26.4B
| – | – |
-7,329
| Closed | -$500K |
|
128
Las Vegas Sands
LVS
$29.6B
| – | – |
-5,880
| Closed | -$221K |
|
129
Wells Fargo
WFC
$264B
| – | – |
-4,777
| Closed | -$229K |
|
|
ATVI
130
DELISTED
Activision Blizzard
ATVI
| – | – |
-15,400
| Closed | -$1.02M |
|
Similar funds
Chiron Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Chiron Capital Management held 130 positions worth $159M, up 15% from $139M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Chiron Capital Management deployed $17.8M of net new capital in Q1 2022, opening 21 new positions and adding to 51 existing holdings. Its largest new stake was Skyworks Solutions: 7,326 shares worth $976K.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 44% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $6.43M trimmed.
- Chiron Capital Management's largest Q1 2022 buy was Skyworks Solutions: 7,326 shares worth $976K.
- Chiron Capital Management added most to State Street SPDR S&P Biotech ETF in Q1 2022, an estimated $10.4M increase.
- Chiron Capital Management's biggest Q1 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.43M.
- Chiron Capital Management fully exited Activision Blizzard in Q1 2022, selling an estimated $1.02M.
- Chiron Capital Management's ten largest holdings make up 54% of its $159M portfolio in Q1 2022.
- Chiron Capital Management opened 21 new positions and closed 7 in Q1 2022.
- Chiron Capital Management's portfolio value rose 15% quarter-over-quarter to $159M.
Based on Chiron Capital Management's 13F filing for Q1 2022, filed 18 Apr 2022.